| P2093 | author name string | Ali I Al-Gareeb | |
| | Hayder M Al-Kuraishy | |
| | Marwa S Al-Naimi | |
| | Huda A Rasheed | |
| | Nawar R Hussien | |
| P2860 | cites work | Investigation of zinc and copper levels in methimazole-induced hypothyroidism: relation with the oxidant-antioxidant status | Q46919758 |
| | Altered expression of apoA-I, apoA-IV and PON-1 activity in CBS deficient homocystinuria in the presence and absence of treatment: possible implications for cardiovascular outcomes | Q48493786 |
| | Effect of posttraumatic serum thyroid hormone levels on severity and mortality of patients with severe traumatic brain injury | Q48646447 |
| | Declaration of Helsinki, 2008: implications for stakeholders in research | Q49160916 |
| | Rosuvastatin Improves Vaspin Serum Levels in Obese Patients with Acute Coronary Syndrome | Q50027160 |
| | PON1-108 TT and PON1-192 RR genotypes are more frequently encountered in Greek PCOS than non-PCOS women, and are associated with hyperandrogenaemia. | Q50883350 |
| | Structural changes in the myocardium and serum lipid spectrum in experimental hypercholesterolemia and hypothyroidism. | Q54518151 |
| | Serum paraoxonase 1 activity and oxidative markers of LDL in patients with cardiac syndrome X | Q80560820 |
| | Oxidative stress and enzymatic antioxidant status in patients with hypothyroidism before and after treatment | Q81245493 |
| | Lipid metabolism in subclinical hypothyroidism: plasma kinetics of triglyceride-rich lipoproteins and lipid transfers to high-density lipoprotein before and after levothyroxine treatment | Q83562257 |
| | Paraoxanase as an indicator of myocardial ischemia and its utility in determining extension of ischemia | Q86501996 |
| | Oxidative stress, thyroid dysfunction & Down syndrome | Q26782125 |
| | Effects of Rosuvastatin Alone or in Combination with Omega-3 Fatty Acid on Adiponectin Levels and Cardiometabolic Profile | Q28468474 |
| | Weight Gain and Serum TSH Increase within the Reference Range after Hemithyroidectomy Indicate Lowered Thyroid Function. | Q33735908 |
| | Acylation-stimulating protein is a surrogate biomarker for acute myocardial infarction: Role of statins | Q33868919 |
| | Cardiovascular Risk Factors in Subclinical Hypothyroidism: A Case Control Study in Nepalese Population | Q36189683 |
| | Bioequivalence studies for levothyroxine | Q36250772 |
| | New Insights into the Role of Metformin Effects on Serum Omentin-1 Levels in Acute Myocardial Infarction: Cross-Sectional Study | Q36349750 |
| | Effect of orlistat alone or in combination with Garcinia cambogia on visceral adiposity index in obese patients. | Q37334443 |
| | Maternal hypothyroidism in early pregnancy and infant structural congenital malformations. | Q37679696 |
| | Thyroid hormones and growth in health and disease | Q37900499 |
| | Thyroid hormone and cardiovascular system: from basic concepts to clinical application | Q38084174 |
| | Management of primary hypothyroidism: statement by the British Thyroid Association Executive Committee. | Q38502679 |
| | New insights into mechanisms of cardioprotection mediated by thyroid hormones. | Q39299996 |
| | Thyroid hormone and tissue repair: new tricks for an old hormone? | Q41150368 |
| | Association of Hypothyroidism with Body Mass Index, Systolic Blood Pressure and Proteinuria in Diabetic Patients: Does treated Hypothyroidism with Thyroxine Replacement Therapy Prevent Nephropathy/Chronic Renal Disease? | Q41174341 |
| | Effect of levothyroxine replacement therapy on paraoxonase-1 and carotid intima-media thickness in subclinical hypothyroidism | Q43206664 |
| | HDL-paraoxonase and membrane lipid peroxidation: a comparison between healthy and obese subjects | Q43260384 |
| | Serum paraoxonase 1 activity is decreased in thyroid dysfunction. | Q44689186 |
| | Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation | Q45073574 |
| | Association of serum paraoxonase activity with insulin sensitivity and oxidative stress in hyperthyroid and TSH-suppressed nodular goitre patients | Q45097790 |
| | Serum total antioxidant status and lipid peroxidation marker malondialdehyde levels in overt and subclinical hypothyroidism | Q45738379 |
| | Thyroid substitution therapy induces high-density lipoprotein-associated platelet-activating factor-acetylhydrolase in patients with subclinical hypothyroidism: a potential antiatherogenic effect. | Q46522025 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 113-118 | |
| P1433 | published in | Journal of Advanced Pharmaceutical Technology and Research | Q15817467 |
| P1476 | title | Levothyroxine improves Paraoxonase (PON-1) serum levels in patients with primary hypothyroidism: Case-control study | |
| P478 | volume | 9 | |